GSK's Revolutionary Leap in Environmental Sustainability: The Low-Carbon Ventolin Inhaler
GlaxoSmithKline (GSK) announces a groundbreaking initiative to significantly reduce carbon emissions with a next-gen Ventolin inhaler. This effort is part of GSK's broader strategy to combat climate change, aiming to lower its carbon footprint by 90% and bolster environmental sustainability.